These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 495621)

  • 1. Aminoglycoside use monitored by clinical pharmaceutical services.
    Barriere SL; Conte JE
    Am J Hosp Pharm; 1979 Sep; 36(9):1209-11. PubMed ID: 495621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-benefit analysis of an aminoglycoside monitoring service.
    Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B
    Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist interventions to improve prescribing of vancomycin and tobramycin.
    Fletcher CV; Giese RM; Rodman JH
    Am J Hosp Pharm; 1986 Sep; 43(9):2198-201. PubMed ID: 3766572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective audit of an aminoglycoside consultative service in a general hospital.
    Li SC; Ioannides-Demos LL; Spicer WJ; Spelman DW; Tong N; McLean AJ
    Med J Aust; 1992 Sep; 157(5):308-11. PubMed ID: 1435470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost savings associated with use of gentamicin versus tobramycin.
    Schwinghammer TL; Romano MJ; Wing EJ
    Am J Hosp Pharm; 1985 Aug; 42(8):1745-9. PubMed ID: 4036972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pharmacy intervention on aminoglycoside costs.
    Tsuyuki RT; Nakagawa RS
    Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
    Possidente CJ; Lynch T
    Hosp Pharm; 1988 Nov; 23(11):976-8, 981-3. PubMed ID: 10290757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aminoglycoside-use restrictions on drug cost.
    DeTorres OH; White RE
    Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pharmacist consultation on rational antimicrobial therapy.
    Witte KW; Nelson AA; Hutchinson RA
    Am J Hosp Pharm; 1980 Jun; 37(6):829-32. PubMed ID: 7395878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Culture and antibiotic monitoring service in a community hospital.
    Von Seggern RL
    Am J Hosp Pharm; 1987 Jun; 44(6):1358-62. PubMed ID: 3303924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
    Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
    Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial impact of an aminoglycoside substitution program.
    Andrews JD; Stad K
    Can J Hosp Pharm; 1987 Feb; 40(1):23-6. PubMed ID: 10281256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the impact of education by a clinical pharmacist on antibiotic prescribing and administration in an acute care state psychiatric hospital.
    Thompson BF; Miller WA; Wells BG; Rawls WN
    Hosp Pharm; 1986 Nov; 21(11):1056-62. PubMed ID: 10279323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical considerations and costs associated with formulary conversion from tobramycin to gentamicin.
    Green ER; Chrymko MM; Rozek SL; Kitrenos JG
    Am J Hosp Pharm; 1989 Apr; 46(4):714-9. PubMed ID: 2719049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors potentially influencing aminoglycoside use and expenditure.
    DiPiro JT; Kilsdonk GF; Amerson AB; Record KE
    Am J Hosp Pharm; 1982 Jul; 39(7):1180-3. PubMed ID: 7114060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
    Khanderia U
    Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Control of serum levels of tobramycin and amikacin during clinical routine treatment conditions (author's transl)].
    Stark GB; Eiermann T; Langmaack H; Daschner F
    Dtsch Med Wochenschr; 1982 Aug; 107(31-32):1182-4. PubMed ID: 7105995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling the costs of antibiotic resistance.
    North D
    Clin Ther; 1993; 15 Suppl A():3-11. PubMed ID: 8513459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.